These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A clinicoepidemiological study of pityriasis rosea in South India. Ganguly S Skinmed; 2013; 11(3):141-6. PubMed ID: 23930352 [TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea. Kim DH; Cho JH; Park SJ; Seo SH; Ahn HH J Korean Med Sci; 2022 Jun; 37(24):e190. PubMed ID: 35726143 [TBL] [Abstract][Full Text] [Related]
15. Vesicular pityriasis rosea: response to erythromycin treatment. Miranda SB; Lupi O; Lucas E J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):622-5. PubMed ID: 15324412 [TBL] [Abstract][Full Text] [Related]
16. Pityriasis rosea: an important papulosquamous disorder. González LM; Allen R; Janniger CK; Schwartz RA Int J Dermatol; 2005 Sep; 44(9):757-64. PubMed ID: 16135147 [No Abstract] [Full Text] [Related]
18. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. Drago F; Broccolo F; Rebora A J Am Acad Dermatol; 2009 Aug; 61(2):303-18. PubMed ID: 19615540 [TBL] [Abstract][Full Text] [Related]